Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00927
|
|||||
| Drug Name |
Osanetant
|
|||||
| Synonyms |
Osanetant [INN]; 160492-56-8; CHEMBL346178; K7G81N94DT; N-(1-(3-((3R)-1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl)propyl)-4-phenyl-4-piperidinyl)-N-methylacetamide; N-(1-(3-((R)-1-Benzoyl-3-(3,4-dichlorophenyl)-3-piperidyl)propyl)-4-phenyl-4-piperidyl)-N-methylacetamide; N-(1-{3-[(3r)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl)-n-methylacetamide; N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-N-methylacetamide; Osanetant [INN]; SB-236984; SR 142801; SR-14280; SR-142801; SR-142806; SR142801; UNII-K7G81N94DT; [3H]osanetant; n-(1-{3-[(3r)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl)-n-methylacetamide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C35H41Cl2N3O2
|
|||||
| Canonical SMILES |
CC(=O)N(C)C1(CCN(CC1)CCCC2(CCCN(C2)C(=O)C3=CC=CC=C3)C4=CC(=C(C=C4)Cl)Cl)C5=CC=CC=C5
|
|||||
| InChI |
InChI=1S/C35H41Cl2N3O2/c1-27(41)38(2)35(29-13-7-4-8-14-29)19-23-39(24-20-35)21-9-17-34(30-15-16-31(36)32(37)25-30)18-10-22-40(26-34)33(42)28-11-5-3-6-12-28/h3-8,11-16,25H,9-10,17-24,26H2,1-2H3/t34-/m0/s1
|
|||||
| InChIKey |
DZOJBGLFWINFBF-UMSFTDKQSA-N
|
|||||
| CAS Number |
CAS 160492-56-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 606.6 | Topological Polar Surface Area | 43.9 | ||
| Heavy Atom Count | 42 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
7
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.